腹腔镜根治性肾输尿管切除术中穿刺孔转移的发生率:单中心经验
本研究回顾性分析本中心240例上尿路尿路上皮癌患者行腹腔镜根治性肾输尿管切除术的资料,中位随访12.6个月后4例(1.7%)出现穿刺孔转移。作者认为后腹腔途径漏气、高肿瘤分期(pT3)和分级、晚期肾盂肿瘤伴微转移可能增加穿刺孔转移风险。
要点
- 腹腔镜根治性肾输尿管切除术后穿刺孔转移发生率为1.7%(4/240)。
- 穿刺孔转移患者中肿瘤分期为T2N0M0一例、T3N0M0两例、T3N1M0一例,均为高级别尿路上皮癌。
- 作者建议后腹腔途径漏气、高肿瘤分期(pT3)和分级、晚期肾盂肿瘤伴微转移可能增加穿刺孔转移风险。
核心结论
- 腹腔镜根治性肾输尿管切除术后穿刺孔转移发生率为1.7%(4/240),作者建议后腹腔途径漏气、高肿瘤分期(pT3)和分级、晚期肾盂肿瘤伴微转移可能增加穿刺孔转移风险。
研究设计与样本
- 回顾性收集2013年1月至2018年12月在本中心接受腹腔镜根治性肾输尿管切除术的240例上尿路尿路上皮癌患者的临床资料,其中肾盂肿瘤145例、输尿管肿瘤135例(40例同时存在两种肿瘤),经腹腔途径28例、后腹腔途径212例。
主要发现
- 中位随访12.6个月(范围3-45个月)后,4例(1.7%)后腹腔途径根治性肾输尿管切除术后出现穿刺孔转移,平均发生于术后4.3个月。
- 穿刺孔转移患者肿瘤分期分别为T2N0M0一例、T3N0M0两例、T3N1M0一例,肿瘤分级均为高级别尿路上皮癌。
- 肾盂肿瘤和输尿管肿瘤的穿刺孔转移发生率分别为2.8%(4/145)和0.7%(1/135)。
临床怎么用
- 作者建议后腹腔途径漏气、高肿瘤分期(pT3)和分级、晚期肾盂肿瘤伴微转移可能增加穿刺孔转移风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To address the incidence and potential risk factors of port site metastasis (PSM) in patients who underwent laparoscopic radical nephroureterectomy (RNU) for upper tract urothelial carcinoma. MATERIALS AND METHODS: Between January 2013 and December 2018 laparoscopic RNU were performed in 240 patients at our institution, including 145 with renal pelvic tumor and 135 with ureteral tumor (40 patients have both tumor). Laparoscopies were performed through the transperitoneal approach in 28 patients, and retroperitoneal in 212 patients. Clinical data are retrospectively collected. RESULTS: Perioperative and pathologic data are available in all 240 cases. After a mean follow-up of 12.6 months (range 3-45 months), 4 patients (1.7%) developed PSM following retroperitoneal RNU at an average of 4.3 months. Tumor stage is T2N0M0 in one, T3N0M0 in two, and T3N1M0 in one, respectively. Tumor grade are high-grade urothelial carcinoma in all. The incidence of PSM is 2.8% (4/145) and 0.7% (1/135) in renal pelvic and ureteral tumor, respectively. CONCLUSION: We report a 1.7% incidence of PSM in upper tract urothelial carcinoma after laparoscopic RNU. We suggest that air leakage during retroperitoneal approach, high tumor stage (pT3) and grade, and advanced renal pelvic tumor with micrometastases could increase the potential risks of PSM.
引用
- Kang Q, Yu Y, Yang B, et al. Incidence of Port Site Metastasis in Laparoscopic Radical Nephroureterectomy: Single-institution Experience. Urology. 2019. PMID: 31202854. doi:10.1016/j.urology.2019.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。